Lisa Weller, Regina Poß-Doering, Thomas Grobe, Thomas Fleischhauer, Gunter Laux, Jona Frasch, Attila Altiner, Kerstin Protz, Joachim Szecsenyi, Jonas D. Senft
{"title":"Outpatient care for venous leg ulceration in Germany: A retrospective claims data analysis","authors":"Lisa Weller, Regina Poß-Doering, Thomas Grobe, Thomas Fleischhauer, Gunter Laux, Jona Frasch, Attila Altiner, Kerstin Protz, Joachim Szecsenyi, Jonas D. Senft","doi":"10.1111/ddg.70021","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background and objectives</h3>\n \n <p>Outpatient care of venous leg ulcers (VLU) is a problem of high medical and health economic relevance. Treatment is often inconsistent and not guideline-compliant. The project Ulcus Cruris Care investigated the VLU outpatient care situation in Germany.</p>\n </section>\n \n <section>\n \n <h3> Patients and methods</h3>\n \n <p>Reimbursement data of 40,046 patient cases (2015–2019) with VLU diagnosis from a statutory health insurer (AOK Baden-Wuerttemberg, Germany) were retrospectively analyzed. Outcome assessment was based on prescriptions, medical aids, nursing care, use of compression devices, surgical procedures and treatment costs.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>47.3% (n = 7,581) of patients without contraindication received a compression device within 90 days. 2.3% (n = 135) received surgical truncal vein interventions. 14.1% (n = 771) received consistent compression therapy associated with faster wound healing (121.6 ± 86.2 vs. 188.1 ± 164.2 days, p < 0.001), lower total costs (4,280 ± 5,326 € vs. 5,683 ± 9,657 €, p < 0.001) and lower disease-specific costs (2,498 ± 2,785 € vs. 2,797 ± 5,145 €, p = 0.017) versus no or unsteady treatment.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>In outpatient VLU care around 80% of patients do not receive consistent compression therapy and are therefore not adequately treated. There is an urgent need for action to improve treatment of patients with VLU in Germany.</p>\n </section>\n </div>","PeriodicalId":14758,"journal":{"name":"Journal Der Deutschen Dermatologischen Gesellschaft","volume":"24 10","pages":"e1426-e1433"},"PeriodicalIF":5.0000,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ddg.70021","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal Der Deutschen Dermatologischen Gesellschaft","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ddg.70021","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/12 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives
Outpatient care of venous leg ulcers (VLU) is a problem of high medical and health economic relevance. Treatment is often inconsistent and not guideline-compliant. The project Ulcus Cruris Care investigated the VLU outpatient care situation in Germany.
Patients and methods
Reimbursement data of 40,046 patient cases (2015–2019) with VLU diagnosis from a statutory health insurer (AOK Baden-Wuerttemberg, Germany) were retrospectively analyzed. Outcome assessment was based on prescriptions, medical aids, nursing care, use of compression devices, surgical procedures and treatment costs.
Results
47.3% (n = 7,581) of patients without contraindication received a compression device within 90 days. 2.3% (n = 135) received surgical truncal vein interventions. 14.1% (n = 771) received consistent compression therapy associated with faster wound healing (121.6 ± 86.2 vs. 188.1 ± 164.2 days, p < 0.001), lower total costs (4,280 ± 5,326 € vs. 5,683 ± 9,657 €, p < 0.001) and lower disease-specific costs (2,498 ± 2,785 € vs. 2,797 ± 5,145 €, p = 0.017) versus no or unsteady treatment.
Conclusions
In outpatient VLU care around 80% of patients do not receive consistent compression therapy and are therefore not adequately treated. There is an urgent need for action to improve treatment of patients with VLU in Germany.
期刊介绍:
The JDDG publishes scientific papers from a wide range of disciplines, such as dermatovenereology, allergology, phlebology, dermatosurgery, dermatooncology, and dermatohistopathology. Also in JDDG: information on medical training, continuing education, a calendar of events, book reviews and society announcements.
Papers can be submitted in German or English language. In the print version, all articles are published in German. In the online version, all key articles are published in English.